Case Study

Flexible IRT Platform Solution For National Lung Cancer Trial


Cenduit IRT currently provides randomization and trial supply management for the world’s largest precision medicine trial to investigate treatment for non-small cell lung cancer. This trial is investigating genetic biomarker targeted therapy combinations, via partnership between non-profit research organizations and large pharmaceutical companies.

Trial design for this type of study presents unique challenges. These include the need for an IRT platform that can support the rapid incorporation of amendments and account for multiple or potential arms which require different lists of material types and dosages that could be prescribed to patients and supplied to sites. Cenduit’s highly-configurable, flexible technology platform was the solution.

access the Case Study!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader